Quarterly report [Sections 13 or 15(d)]

Schedule of receivables with imputed interest (Details)

v3.26.3
Schedule of receivables with imputed interest (Details) - USD ($)
 9 Months Ended
Sep. 01, 2026
Sep. 30, 2026
Dec. 31, 2025
Jun. 11, 2024
Receivables [Abstract]        
Face value   $ 111,839 [1] $ 287,200 [1] $ 287,200
Impairment   (74,847) (250,208) 250,208
Total   36,992 36,992  
Unamortized discount   (36,992) (36,992) $ (36,992)
Net balance    
Long term portion    
Impaired investment $ 175,361 $ 175,361    
[1] The face value amount was reduced by $175,361 due to the award by order of the Superior Court, County of Fresno on September 1, 2026. Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.